These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 2037370

  • 1. Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G.
    Cutler CW, Kalmar JR, Arnold RR.
    Infect Immun; 1991 Jun; 59(6):2097-104. PubMed ID: 2037370
    [Abstract] [Full Text] [Related]

  • 2. Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.
    Cutler CW, Kalmar JR, Arnold RR.
    Infect Immun; 1991 Jun; 59(6):2105-9. PubMed ID: 2037371
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis.
    Cutler CW, Arnold RR, Schenkein HA.
    J Immunol; 1993 Dec 15; 151(12):7016-29. PubMed ID: 8258706
    [Abstract] [Full Text] [Related]

  • 4. Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes.
    Fan Q, Sims T, Sojar H, Genco R, Page RC.
    Oral Microbiol Immunol; 2001 Jun 15; 16(3):144-52. PubMed ID: 11358536
    [Abstract] [Full Text] [Related]

  • 5. Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis.
    Nakagawa T, Sims T, Fan Q, Potempa J, Travis J, Houston L, Page RC.
    Oral Microbiol Immunol; 2001 Aug 15; 16(4):202-11. PubMed ID: 11442844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated opsonic activity for Porphyromonas (Bacteroides) gingivalis in serum from patients with a history of destructive periodontal disease. A case: control study.
    Wilton JM, Hurst TJ, Sterne JA.
    J Clin Periodontol; 1993 Sep 15; 20(8):563-9. PubMed ID: 8408718
    [Abstract] [Full Text] [Related]

  • 9. Opsonophagocytic effect of antibody against recombinant conserved 40-kDa outer membrane protein of Porphyromonas gingivalis.
    Saito S, Hayakawa M, Takiguchi H, Abiko Y.
    J Periodontol; 1999 Jun 15; 70(6):610-7. PubMed ID: 10397516
    [Abstract] [Full Text] [Related]

  • 10. Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.
    Guentsch A, Puklo M, Preshaw PM, Glockmann E, Pfister W, Potempa J, Eick S.
    J Periodontal Res; 2009 Jun 15; 44(3):368-77. PubMed ID: 19210340
    [Abstract] [Full Text] [Related]

  • 11. Influence of immunization on Porphyromonas gingivalis colonization and invasion in the mouse chamber model.
    Genco CA, Kapczynski DR, Cutler CW, Arko RJ, Arnold RR.
    Infect Immun; 1992 Apr 15; 60(4):1447-54. PubMed ID: 1312515
    [Abstract] [Full Text] [Related]

  • 12. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T, Frisk A, Purvèn M, Nilsson LA.
    Microb Pathog; 1995 Jan 15; 18(1):37-51. PubMed ID: 7783597
    [Abstract] [Full Text] [Related]

  • 13. Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.
    Wilson ME, Bronson PM, Hamilton RG.
    Infect Immun; 1995 Mar 15; 63(3):1070-5. PubMed ID: 7868229
    [Abstract] [Full Text] [Related]

  • 14. Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis.
    Gibson FC, Savelli J, Van Dyke TE, Genco CA.
    J Periodontol; 2005 Oct 15; 76(10):1629-36. PubMed ID: 16253083
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phagocytosis of Porphyromonas gingivalis and Prevotella intermedia by human polymorphonuclear leukocytes in clots formed from human plasma or purified fibrinogen.
    Hurst TJ, Wilton JM.
    J Periodontal Res; 1992 Mar 15; 27(2):111-8. PubMed ID: 1312590
    [Abstract] [Full Text] [Related]

  • 18. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I, Joris L, Hsu YP, Van Wye J, Bram R, Moss R.
    J Clin Invest; 1989 Dec 15; 84(6):1794-804. PubMed ID: 2512330
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.